ELVNEnliven Therapeutics, Inc.

$40.98+116% 1Y

Is the price fair?

What ELVN's price assumes

Price / book
3.63

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
3.63
Market capitalisation
$3.51B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks